Product Description:

Tafamidis is a medication used for the treatment of transthyretin amyloid cardiomyopathy and polyneuropathy, which are forms of transthyretin amyloidosis.

Applications & Uses:

• Therapeutic Development
• Pharmaceutical Applications
• Therapeutic Innovations
• Neurological Research
• Cardioprotective
• Pharmaceutical Research
• Construction Materials
• Therapeutic Interventions
• Oral Hygiene
• Dietary Implications
• Human Medicine

CAS#:

594839-88-0

SYNONYM:

Tafamidis;PF-06291826;Vyndaqel

FORMULA:

C14H7Cl2F3NO3

PRODUCT TYPE:

HAZARD:

Warning

CATEGORIES:

Pharmaceutical